Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-25 @ 2:11 PM
Study NCT ID:
NCT04720092
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2021-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-20
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-20
Last Update Post Date:
2021-01-22
Last Update Post Date Type:
ACTUAL